Psivant Therapeutics is advancing a paradigm shift in biotechnology by pioneering a physics-driven approach to drug design that is tightly coupled to chemistry and biology research and development. Our QUAISAR platform is purpose-built to develop novel small molecule therapeutics to address biologically and genetically validated, but previously intractable, protein targets.
Company Details
- Employees
- 34
- Founded
- -
- Address
- 451 D Street, Boston,ma 02210,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://psivant.com
- Keywords
- Barcelona.
- HQ
- Boston, MA
Psivant Therapeutics Questions
Psivant Therapeutics's website is http://psivant.com
Psivant Therapeutics's LinkedIn profile is https://www.linkedin.com/company/psivant-therapeutics
Psivant Therapeutics has
34 employees.
View email and phone details for 34
employees at Psivant Therapeutics.
Psivant Therapeutics's industry is
Biotechnology Research
Psivant Therapeutics's top competitors are
Vertex Pharmaceuticals,
Roivant,
Vantai,
Immunovant,
Accent Therapeutics, Inc.,
Generate:biomedicines,
Covant Therapeutics,
Acellera Therapeutics,
Ventus Therapeutics,
Schrödinger.
Psivant Therapeutics's categories are Biotechnology Research
Psivant Therapeutics's founding year is 2022
